Yakob Liawatidewi - 14 May 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
14 May 2021
Net transactions value
-$146,952
Form type
4
Filing time
18 May 2021, 16:06:23 UTC
Previous filing
13 May 2021
Next filing
08 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Sale $63,454 -3,186 -5.6% $19.92 53,573 14 May 2021 Direct F1
transaction AMPH Common Stock Options Exercise $109,187 +9,637 +18% $11.33* 63,210 17 May 2021 Direct
transaction AMPH Common Stock Sale $192,686 -9,637 -15% $19.99 53,573 17 May 2021 Direct F2
holding AMPH Common Stock 2,459 14 May 2021 See footnote. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Empoyee Stock Option (right to buy) Options Exercise $0 -9,637 -100% $0.000000* 0 17 May 2021 Common Stock 9,637 $11.33 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.89 to $19.93, inclusive.The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.98 to $20.063, inclusive.
F3 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
F4 Shares subject to the option are fully vested and immediately exercisable.